12,212
Views
10
CrossRef citations to date
0
Altmetric
Review

Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies

, , , , , & show all
Pages 365-373 | Received 19 Feb 2021, Accepted 12 Mar 2021, Published online: 14 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Gatta K. R. S. Naresh & Lalitha Guruprasad. (2023) Mutations in the receptor-binding domain of human SARS CoV-2 spike protein increases its affinity to bind human ACE-2 receptor. Journal of Biomolecular Structure and Dynamics 41:6, pages 2368-2381.
Read now
Chin Peng Lim, Boon Hui Kok, Hui Ting Lim, Candy Chuah, Badarulhisam Abdul Rahman, Abu Bakar Abdul Majeed, Michelle Wykes, Chiuan Herng Leow & Chiuan Yee Leow. (2023) Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design. Pathogens and Global Health 117:2, pages 134-151.
Read now
Lianlian Bian, Jianyang Liu, Fan Gao, Qiushuang Gao, Qian He, Qunying Mao, Xing Wu, Miao Xu & Zhenglun Liang. (2022) Research progress on vaccine efficacy against SARS-CoV-2 variants of concern. Human Vaccines & Immunotherapeutics 18:5.
Read now
Qian Wang, Xing Wu, Qunying Mao, Fan Gao, Mingchen Liu, Ziyang Song, Lianlian Bian & Zhenglun Liang. (2022) How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review. Expert Review of Anti-infective Therapy 20:8, pages 1119-1127.
Read now
Amresh Kumar, Amit Ladha, Ankita Choudhury, Abu Md Ashif Ikbal, Bedanta Bhattacharjee, Tanmay Das, Gaurav Gupta, Chhavi Sharma, Adity Sarbajna, Subhash C Mandal, Manabendra Dutta Choudhury, Nahid Ali, Petr Slama, Nima Rezaei, Partha Palit & Onkar Nath Tiwari. (2022) The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19?. Expert Review of Vaccines 21:8, pages 1071-1086.
Read now
Yu Bai, Qian Wang, Mingchen Liu, Lianlian Bian, Jianyang Liu, Fan Gao, Qunying Mao, Zhongfang Wang, Xing Wu, Miao Xu & Zhenglun Liang. (2022) The next major emergent infectious disease: reflections on vaccine emergency development strategies. Expert Review of Vaccines 21:4, pages 471-481.
Read now
Nan-Chang Chiu, Hsin Chi, Yu-Kang Tu, Ya-Ning Huang, Yu-Lin Tai, Shun-Long Weng, Lung Chang, Daniel Tsung-Ning Huang, Fu-Yuan Huang & Chien-Yu Lin. (2021) To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination. Expert Review of Vaccines 20:10, pages 1211-1220.
Read now

Articles from other publishers (3)

Yinghan Chan, Sin Wi Ng, Sachin Kumar Singh, Monica Gulati, Gaurav Gupta, Sushil Kumar Chaudhary, Goh Bey Hing, Trudi Collet, Ronan MacLoughlin, Raimar Löbenberg, Brian G. Oliver, Dinesh Kumar Chellappan & Kamal Dua. (2021) Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Life Sciences 280, pages 119744.
Crossref
Mohamed A. Farrag, Haitham M. Amer, Rauf Bhat, Maaweya E. Hamed, Ibrahim M. Aziz, Ayman Mubarak, Turki M Dawoud, Sami G Almalki, Fayez Alghofaili, Ahmad K. Alnemare, Raid Saleem Al-Baradi, Bandar Alosaimi & Wael Alturaiki. (2021) SARS-CoV-2: An Overview of Virus Genetics, Transmission, and Immunopathogenesis. International Journal of Environmental Research and Public Health 18:12, pages 6312.
Crossref
Peter A. C. Maple. (2021) Population (Antibody) Testing for COVID-19—Technical Challenges, Application and Relevance, an English Perspective. Vaccines 9:6, pages 550.
Crossref